Synopsis:
Pidilite Industries announced a board meeting on August 6, 2025, to consider a special interim dividend and bonus shares, signalling potential rewards for shareholders.
Known for its innovative solutions in the speciality chemicals sector, this company is generating buzz as it prepares for a crucial board meeting on August 6 to discuss financial results, a potential special interim dividend, and bonus shares. Investors can expect exciting updates and possible shareholder rewards in the upcoming announcement.
Pidilite Industries Limited’s stock, with a market capitalisation of Rs. 1,49,162 crores, rose to Rs. 2,952.90, hitting a high of up to 3.28 percent from its previous closing price of Rs. 2,858.90. However, the stock over the past year has given a negative return of 4.60 percent.
Dividend & Bonus
A board meeting is scheduled for August 6, 2025, to approve financial results, consider a special interim dividend, and discuss issuing bonus shares. The trading window for company securities will stay closed until August 8, 2025.
Company Portfolio
Pidilite Industries 2025 portfolio is divided into core, growth, and pioneer segments. Core brands like Fevicol, Fevi Kwik, and M-Seal lead the adhesives market. Growth brands, including Dr. Fixit, WD-40, and Roff, target new markets and categories.
Pioneer brands such as Dr. Cipy and Fevi Seal focus on innovative, advanced solutions. This diversified lineup helps Pidilite strengthen its market position and drive future growth.
Also read: 1:5 Stock Split: Stock jumps 5% after announcing strong Q1 results and share split
Q4 Financial Highlight
In Q4FY25, the company reported revenues of Rs. 3,141 crore, marking an 8.2 percent year-on-year (YoY) increase from Rs. 2,902 crore in Q4FY24. However, revenue declined by 6.8 percent quarter-on-quarter (QoQ) from Rs. 3,369 crore in Q3FY25. Over the past three years, the sales CAGR stood at 10 percent, reflecting steady top-line growth.
Net profit in Q4FY25 was Rs. 428 crore, up 40.8 percent YoY from Rs. 304 crore in Q4FY24, but down 23.2 percent QoQ compared to Rs. 557 crore in Q3FY25. The company delivered a 3-year profit CAGR of 20 percent and a 3-year ROE CAGR of 22 percent, indicating robust profitability and efficient capital utilisation over the medium term.
Written By Fazal Ul Vahab C H
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
